D-6-fatty acid desaturase (FADS2) is the key enzyme in the biosynthesis of polyunsaturated fatty acids (PUFAs), the essential structural determinants of mammalian membrane lipid-bilayers. We developed the auxotrophic fads2 À/À mouse mutant to assess the enigmatic role of x3-and x6-PUFAs in lipid homeostasis, membrane structure and function. Obesity resistance is another major phenotype of the fads2 À/À mutant, the molecular basis of which is unknown. Phospholipidomic profiling of membrane systems of fads2
Introduction
The role of x3-and x6-PUFAs in lipid homeostasis and related imbalances in several pathologies have been the subject of intense research for several decades [1] . Evidence accumulating during the last decades suggests that the genetic basis of lipid homeostasis is critically regulated by epigenetic factors, particularly nutritional imbalances. The x3/x6-PUFA ratio in the Western diet is regarded as the driving force in the development of chronic metabolic, vascular [2] [3] [4] [5] , psychiatric and neurodegenerative disorders [6] .
Dietary studies have been the approach to better define the systemic role of x3-and x6-PUFAs in lipid homeostasis and the molecular pathogenesis of these diseases. Subsequently, a broad range of therapeutic implementations have been proposed. However, until the precise roles of x3-and x6-PUFAs are better understood, treatment of PUFA-related diseases may not be adequate.
Mammalian cells transform essential fatty acids (EFAs) x3-a-linolenic (a-18:3; ALA) and x6-linoleic (18:2; LA) acid at fatty acid desaturase-and elongase-complexes, localized in the endoplasmic reticulum (ER), into long-chain x3-and x6-PUFA families, that include x3-eicosapentaenoic (20:5 5, 8, 11, 14, 17 , EPA), x3-docosahexaenoic acid(22:6 4, 7, 10, 13, 16, 19 , DHA), x6-di-homo-c-linolenic (20:3 8, 11, 14 ), and x6-arachidonic acid (20:4 5, 8, 11, 14 , AA). PUFAs are incorporated into the diacylglycerol (DAG)-backbone of respective phospholipids (PLs) by specific acyl-transferases during de novo synthesis [7] or by the deacylation-reacylation cycle [8] . PLs are amphipathic molecules with 'dove tail' functions, asymmetrically distributed in the outer leaflet [phosphatidyl-choline (PC) and sphingomyelin (SM)] and inner leaflet [phosphatidyl -ethanolamine, PE, -inositol, PI, -serine, PS and bis-phosphatidyl-glycerol, CL (cardiolipin)]. PUFAs are structural determinants within the hydrophobic DAG-core, where they contribute to the hydrophobic scaffold of functionally divergent integral membrane proteins. Their polar head groups at the membrane surface function as docking sites of protein domains in cellular transport and cell signaling.
We applied the loss of structure-function strategy to studies in vivo on the molecular mechanism(s) underlying the structural and metabolic role of individual PUFAs. This approach has become feasible in the fads2 À/À mouse mutant [9] . Systemic absence of PUFAs and auxotrophy of the fads2 À/À mouse mutant are essential prerequisites for conclusive dietary studies in vivo.
Infertility of male and female fads2 À/À mice was the first dominant phenotype analyzed [9] . The rescue of male and female fertility by a 22:6-(DHA) supplemented diet gave the first hint at the auxotrophy of the fads2 À/À mutant. Incorporation of specifically DHA into PLs of Sertoli and follicular granulosa cells rescued cell polarity, germ cell maturation and fertility. These results have been confirmed in another fads2 À/À mouse model [10, 11] .
We report here on another major phenotype of the fads2 À/À mutant, perturbed lipogenesis and obesity resistance, and the molecular link to PUFA deficiency. Profiling of the membrane phospholipidomes of the metabolically most active tissues, liver, muscle, brown adipose tissue (BAT) and white adipose tissue (WAT) generated the structural platform for the phenotypic characterization.
The first striking observation was the activation of a novel abnormal pathway, by which LA acid was transformed into the eicosatrienoic acid x6-20:3 ' mouse line with solely AA and DHA, respectively. These three well defined mouse lines of fads2 À/À expand the scope of studies, which target the numerous proposed but experimentally unproven functions of PUFAs in normal and disease conditions.
Results and Discussion
Fads2 À/À mice show obesity resistance FADS2-deficient mice are obesity-resistant. Adult male and female nd-fads2 À/À mice are lean and 10-15% smaller in body size than nd +/+ mice (Fig 1A and B (Fig 1G and H) .
Situs of age-and gender-matched nd-, AA-and DHA +/+ and À/À littermates underlined these parameters (supplementary Fig S1A-F) . Fig S1I) . DHA +/+ and DHA À/À mice, however, were hyperphagic (supplementary Fig S1J) . Metabolic parameters (VO 2 uptake, VCO 2 production, and heat dissipation) of nd À/À mice were reduced by approximately one third compared to control mice (supplementary Fig S2C-E) , but comparable and unchanged in AAor DHA +/+ and À/À mice. RER reflected a balanced carbohydrate and fat utilization by the three cohorts (supplementary Fig S2) . Enhanced energy production due to perturbed epidermal lipid barrier with trans-epidermal water loss (TEWL) and associated metabolic waste syndrome were excluded by measurement of TEWL of the nd-fads2 D, E NMR-spectroscopy revealed significantly reduced% fat mass (D) and correspondently elevated% lean mass of body weight in fads2 À/À (n = 10) (E). (Fig 1I) showed a significantly retarded return to normal serum glucose concentration in the nd À/À mouse during the 2 h period post intraperitoneal insulin application, suggesting reduced insulin sensitivity, which is also reflected in the insulin tolerance test (ITT) (Fig 1J) . GTTs and ITTs of AA-and DHA +/+ and À/À mice showed a similar responses (Fig 1K-N) .
Severe perturbationof the nd-fads2 The first surprising discovery was the induction of a futile biosynthetic pathway, by which LA was transformed into a novel non-mammalian all-cis-eicosa-5,11,14-trienoic acid (20:3 5, 11, 14 ) for substitution of PL-associated DAGs in the fads2 À/À mouse (Fig 2A  and B) . 20:3 5, 11, 14 was systemically incorporated as a surrogate of AA and PUFAs in the main PL classes PC, PI, PS and PE, not in cardiolipin (Fig 2C and D) . The structure of this unusual PL constituent was established unambiguously by GC/MS analysis of its DMOX (2,2-dimethyl oxazoline) derivative. DMOX derivatives of PUFAs release diagnostic fragments in MS, characteristic of the methylen-interrupted doublebond systems [12] [13] [14] [15] .The analytical data were identical with those of synthetic DMOX-20:3 5,11,14 [16] and spectra from published data [13] (Fig 2E and F) . The double-bond positions of 20:3 5,11,14 were confirmed finally by oxidative ozonolysis, which released the expected adipic and glutaric acids, identified as dimethylesters by GC/MS, (supplementary Fig S3) . The analytical data suggested the activation of a novel futile pathway from LA via chain elongation to 20:2 11, 14 and D5-desaturation to 20:3 5, 11, 14 in the nd À/À mouse.
We next studied the distribution of 20:3 5, 11, 14 in DAGs of PC, PI, PS, and PE in the phospholipidome of liver total lipid extract of nd-fads2 À/À mice and their microsomal and nuclear membrane fractions, muscle, BAT, and WAT (supplementary Fig S4) , the meta- [17] showed no preference for either substrate in de novo synthesis or PL remodelling.
In conclusion, these dietary studies generated three well-defined 
Gene expression of enzymes of lipid metabolism in fads2 À/À mice
We next investigated the expression profiles of genes coding for transcription factors of enzymes involved in lipid metabolism ppara, ß, c, srebp1c, hmgcoas2, hnf1a, hnf4a and enzymes of fatty acid metabolism cpt1 and 2, scd1-3, D5 (fads1) and elongases 2-6 and of gluconeogenesis fruct-1,6-bp, glc-6p and pepck of (i) the nd-fads2 (Fig 5A  and B) , (ii) the AA- (Fig 5C and D) and (iii) the DHA +/+ and À/À mice (Fig 5E and F) by real time qRT-PCR. (i) Gene expression of enzymes involved in gluconeogenesis did not change significantly in nd +/+ and À/À liver, except for the upregulation of glc-6p in DHA À/ À mouse liver (Fig 5A and B) . Also expression of transcription factors of lipogenesis, including ppara, ß, c, hnf1a and hnf4a, and srebp1c, and enzymes of cholesterol synthesis (HMGCoA synthase) were not significantly changed in nd À/À liver. However, steady-state concentrations of the RNA of key enzymes of PUFA synthesis, the SCD1-3 and desaturase D5 (FADS1) subunit of the trimeric microsomal desaturase complexes, and the condensing subunits of the tetrameric elongase complexes ELOVL2, 5 and 6 were remarkably elevated. ELOVL2 in nd-, AA-and DHA À/À liver is essential for the which encodes the elongase of saturated C12-C16 fatty acids and also correlates positively with the severity of hepatosteatosis was overexpressed. These enzymes are major targets of SREBP1c, critically involved in the development of obesity and insulin resistance.
(ii) In AA À/À liver only the expression of pparc, the transcription factor of key enzymes of lipid metabolism, and of elovl2 was significantly upregulated (Fig 5C and D) . (iii) DHA À/À mouse liver showed elevated expression of glc-6p indicating enhanced gluconeogenesis, and of transcription factor srebp1c causing the activation of D5 desaturases (fads1) and elovl2 and elovl5 and of elovl1, the elongase yielding 24:0 to 26:0, required for ceramide synthesis. Expression of scd3, a mouse-specific isoform of stearoyl-CoA desaturase, was down regulated in DHA À/À mice (Fig 5E and F) .
Deregulation of lipogenesis and hepatic steatosis in the fads2 À/À mouse Lipid homeostasis and lipid bilayer structures of the ER and Golgi membranes are stringently controlled by SREBP1c, the key 
EMBO reports
The Authors transcription factor of enzymes of lipogenesis. Cholesterol concentration in the lipid bilayer of the endoplasmic reticulum and Golgi membranes regulates the membrane-bound steps of processing precursor (p)-SREBP1c to mature (m)-SREBP1c for nuclear import [21] . We therefore studied the impact of the perturbed PL bilayer of microsomal (mic) and of nuclear (nuc) membranes of nd +/+ and À/À mice on the posttranslational modification of p-SREBP1c to m-SREBP1c. Western blot analysis of ER-and nuclear membrane lysates using anti-SREBP1c antibodies indicated elevated levels of active m-SREBP1c in the nuclear fraction of nd À/À liver (Fig 5G) , which was confirmed by immunohistochemistry (IHC) (Fig 5H) . Bright field microscopy of Oil red-stained cryo sections of liver of nd À/À mice revealed hepatocytes filled with tiny lipid droplets (steatosis), compared to few larger diameter droplets in nd +/+ hepatocytes ( Fig 5I) . Liver of AA-fads2 +/+ and AA À/À revealed a remarkably similar expression of genes of transcription factors and enzymes of lipogenesis, of except increased expression of pparc and elovl2 (Fig 5C) . Western blot analysis showed a comparable processing of microsomal p-SREBP1c to nuclear m-SREBP1c (Fig 5J) , which is supported by IHC indicating a similar nuclear SREBP1c antigen import (Fig 5K) . AA À/À hepatocytes were almost free of lipid droplets (Fig 5L) . Only DHA À/À liver RNA showed a threefold higher steady-state concentration of screbp1c, of glc-6p, a marker of gluconeogenesis, and of D5-desaturase (fads1), elongases elovl 1, 2 and 5, which are marker enzymes of PUFA metabolism (Fig 5E and F) . Western blot analysis indicated that microsomal p-SREBP1c-and nuclear mSREBP1c exceeded SREBP1c levels in liver of the DHA +/+ mouse (Fig 5M) . IHC on liver cryo sections revealed elevated nuclear import of m-SREBP1c and enhanced fluorescent SREBP1c antigen in nuclei of DHA À/À hepatocytes. Nuclei of DHA À/À hepatocytes were heavily loaded with SREBP1c reactive peptides (Fig 5N) . Oil redstained sections of DHA +/+ and À/À hepatocytes unveiled hepatic steatosis, characterized by heavy peri-nuclear macro-lipid droplet accumulation. Hepatocytes of DHA +/+ and À/À mice differed in number and size of lipid droplets. DHA +/+ liver showed heavy steatosis, which was ameliorated in hepatocytes of DHA À/À mice (Fig 5O) .
Conclusion
The genetically and biochemically well-defined auxotrophic fads2 
Materials and Methods

Reagents
The following antibodies were used for IHC and Western blot analysis: SREBP1c, a-tubulin, lamin A/C, calnexin and affinity-purified polyclonal anti-polypeptide I192-K444 specific rabbit antibodies [9] . DHASCO and ARASCO (Martek Biosciences, Columbia, MD, USA) were used as sources of docosahexaenoic acid (DHA) and arachidonic acid (AA), respectively. [1-
14 C] Radioactive and inactive 20:3 5, 11, 14 were synthesized in this laboratory [9, 16, 22] . Primers for qRT-PCR are listed under supplementary Table S2 .
Animals
Generation and genotyping of fads2 +/À and À/À mice have been described before [9] . Laboratory measurements Serum concentrations of glucose, insulin, leptin, triglycerides and total cholesterol were determined by standard colorimetric assays [9] .
Glucose-and insulin tolerance tests For GTT and ITT mice were fasted overnight (16 h). Glucose (2 g/kg body weight) was injected intra-peritoneally (ip). For ITT, mice were fasted for 16 h, anesthesized, and insulin (0.5 IU/kg) or saline were injected ip as control. Blood glucose and serum insulin concentrations were determined before and at different times after injection, indicated in the figure legends.
Metabolic measurements
Metabolic parameters (VO 2 , VCO 2 , H, and RER) were determined in the Phenomaster TSL-system, and fat and lean mass by the Bruker Optics minispec TD-NMRAnalyser. TEWL was measured with the Tewameter, model 210 Courage-Khazaka, Cologne, Germany,
Pulse chase experiments
Primary hepatocyte cultures for pulse chase experiments were prepared from fads2 +/+ and À/À mice as previously described [23] .
Details are provided in Supplementary information.
Gene expression RNA preparation and real time quantitative RT-PCR (qRT) are described in Supplementary information.
Western blot analysis
Western blot analysis of cell lysates of fads2 +/+ and À/À liver, muscle, BAT and WAT and nuclear and microsomal proteins of liver is described in Supplementary information.
Immunohistochemistry
Mice were perfused from the left ventricle with PBS and PBS-buffered 4% paraformaldehyde. Organs were fixed and processed for light-and immuno fluorescence microscopy as described in Supplementary information.
Lipid analysis
Isolation, separation, identification and quantification of lipids from organs and subcellular membranes and of fatty acid constituents are described in Supplementary information.
Mass spectroscopy of phospholipids PL classes were analyzed by MS/MS using an Applied Biosystems (Darmstadt, Germany) QTrap analyzer. Conditions are described in Supplementary information.
Oxidative ozonolysis FA mixtures of individual PL classes were dissolved in glacial acetic acid/methylacetate 1:2 (v/v) for oxidative ozonolysis. Methylated oxidation products were analyzed by GC/MS as described in Supplementary information.
Statistical analyses
Data are expressed as means AE s.e.m. Differences between two groups were assessed using the unpaired Student's t-test. Sizes of animal cohorts are listed under respective figures.
Supplementary information for this article is available online: http://embor.embopress.org
